Biopharmaceutical Expression Systems and Genetic Engineering TechnologyBioPlan Associates, Inc.November 1, 2008 415 Pages - SKU: DFAQ2174877 |
|
Freedonia Focus on Biotechnology -- Agriculture: United States
5/31/2012 | published by: Freedonia Focus
This report discusses US demand agricultural biotechnology for the years 2006 and 2011, with forecasts for 2016. Topics covered include market size; product segmentation; genetically modified crops; regulatory considerations; product development; market environment; product forecasts;
|
more...
|
$600.00
|
|
Research Report on Chinese Bio-pharmaceutical Industry, 2012
3/21/2012 | published by: China Research and Intelligence Co., Ltd.
In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including toxins, antigens, allergen, and recombinant DNA products, etc.). In China, animal vaccine belongs to veterinary medicine rather than
|
more...
|
$3,000.00
|
|
Starches and Starch Products in Indonesia: ISIC 1532
3/1/2012 | published by: Euromonitor International
Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Starches and Starch Products market at a national
|
more...
|
$600.00
|
|
The US Pharmaceutical Market Outlook to 2016 - Evolving Opportunities in the Biologics Segment
3/1/2012 | published by: AM Mindpower Solutions
EXECUTIVE SUMMARY The report titled “The US Pharmaceutical Market Outlook to 2015 – Evolving Opportunities in the Biologics Segment” provides a comprehensive analysis on the Pharmaceutical market in the US covering various aspects such as market
|
more...
|
$850.00
|
|
Global Biosimilars Market Forecast to 2015
3/1/2012 | published by: RNCOS
The biosimilars industry has been growing stupendously across the globe for past few years. Increasing healthcare costs and rising aging population are driving the industry, which stands at a vivid position and is expected to
|
more...
|
$1,500.00
|
|
Biologics Market in Brazil
3/2/2012 | published by: Frost & Sullivan
This research service considers the biologics market in Brazil. It covers the market’s move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, blood factors, insulin, filgrastim, interferon,
|
more...
|
$6,000.00
|
|
Starches and Starch Products in Turkey: ISIC 1532
3/1/2012 | published by: Euromonitor International
Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Starches and Starch Products market at a national
|
more...
|
$600.00
|
|
Biosimilars: Current Situation & Future Prospects, Worldwide
3/1/2012 | published by: JustPharmaReports.com
The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry. On this basis, prospects for biosimilars look good, with the vast majority of leading originator brands in the global
|
more...
|
$3,000.00
|
|
Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition
10/15/2011 | published by: Kalorama Information
Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent the fastest growing sector in the pharmaceutical industry. Driving the
|
more...
|
$3,500.00
|
|
Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccines and Biologics
7/1/2011 | published by: Kalorama Information
As researchers work to improve drug properties through drug design and molecular modeling, the line between drug delivery and drug substance will become more and more elusive in the near future, as shown in the
|
more...
|
$2,995.00
|
